Attached files

file filename
EX-32 - CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 - BLACK CACTUS GLOBAL, INC.ex_32-2.htm
EX-32 - CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 - BLACK CACTUS GLOBAL, INC.ex_32-1.htm
EX-31 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) - BLACK CACTUS GLOBAL, INC.ex_31-2.htm
EX-31 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) - BLACK CACTUS GLOBAL, INC.ex_31-1.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - BLACK CACTUS GLOBAL, INC.ex_21-1.htm
EX-4 - DESCRIPTION OF REGISTRANT'S SECURITIES - BLACK CACTUS GLOBAL, INC.ex_4-10.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 10-K

(Mark One)


[X]

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal year ended April 30, 2019


Or


[  ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from              to             


Commission file number 000-55880


Black Cactus Global, Inc.

(Exact name of registrant as specified in its charter)


Florida

 

46-2500923

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

8275 S. Eastern Avenue, Suite 200

Las Vegas, NV

 

89123

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number  (702) 595-2247


Securities registered under Section 12(b) of the Act: None


Securities registered under Section 12(g) of the Act: Common Stock


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ] No [X]


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ] No [X]


Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [  ] No [X]


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer

[  ]

Accelerated filer

[  ]

 

 

 

 

Non-accelerated filer

[  ]

Smaller reporting company

[X]

(Do not check if a smaller reporting company)

 

 

 

 

 

 

 

Emerging growth company

[  ]

 

 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]


The aggregate market value of the common stock held by non-affiliates of the registrant, as of October 31, 2018, the last business day of the second fiscal quarter, was approximately $1,295,371.71 based on a total number of shares of our common stock outstanding on that day of 166,073,296 and a closing price of $0.0078. Shares of common stock held by each director, each officer and each person who owns 10% or more of the outstanding common stock have been excluded from this calculation in that such persons may be deemed to be affiliates. The determination of affiliate status is not necessarily conclusive.


The registrant had 166,073,296 shares of its common stock issued and outstanding as of June 26, 2020.


DOCUMENTS INCORPORATED BY REFERENCE:


None.




TABLE OF CONTENTS

FORM 10-K


 

 

 

 

Page

 

 

 

Part I

 

 

 

 

 

 

Item 1.

 

BUSINESS

 

1

 

Item 1A.

 

RISK FACTORS

 

3

 

Item 1B.

 

UNRESOLVED STAFF COMMENTS

 

3

 

Item 2.

 

PROPERTIES

 

3

 

Item 3.

 

LEGAL PROCEEDINGS

 

3

 

Item 4.

 

MINE SAFETY DISCLOSURES

 

3

 

 

 

 

 

 

Part II

 

 

 

 

 

 

Item 5.

 

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

3

 

Item 6.

 

SELECTED FINANCIAL DATA

 

4

 

Item 7.

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

4

 

Item 7A.

 

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

6

 

Item 8.

 

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

6

 

Item 9.

 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

6

 

Item 9A.

 

CONTROLS AND PROCEDURES

 

7

 

Item 9B.

 

OTHER INFORMATION

 

7

 

 

 

 

 

 

Part III

 

 

 

 

 

 

Item 10.

 

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

8

 

Item 11.

 

EXECUTIVE COMPENSATION

 

12

 

Item 12.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

12

 

Item 13.

 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

13

 

Item 14.

 

PRINCIPAL ACCOUNTING FEES AND SERVICES

 

15

 

 

 

 

 

 

Part IV

 

 

 

 

 

 

Item 15.

 

EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

15

 

 

 

SIGNATURES

 

17

 


- ii -



Part I


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS


Information contained in this Annual Report on Form 10-K contains “forward-looking statements.” These forward-looking statements are contained principally in the sections titled “Business,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology. The forward-looking statements herein represent our expectations, beliefs, plans, intentions or strategies concerning future events, including, but not limited to: our future financial performance; the continuation of historical trends; the sufficiency of our cash balances for future needs; our future operations; the relative cost of our operation methods as compared to our competitors; new production projects, entry and expansion into new markets; achieving status as an industry leader; our competitive advantages over our competitors; brand image; our ability to meet market demands; the sufficiency of our resources in funding our operations; our intention to engage in mergers and acquisitions; and our liquidity and capital needs. Our forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Moreover, our forward-looking statements are subject to various known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. These risks, uncertainties and other factors include but are not limited to: the risks of limited management, labor and financial resources; the risks generally associated with develop stage companies; our ability to establish and maintain adequate internal controls; our ability to develop and maintain a market in our securities; and our ability obtain financing, if and when needed, on terms that are acceptable. Except as required by applicable laws, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.


As used in this Annual Report on Form 10-K “we”, “our”, “us”, the “Company” and “Black Cactus” refer to Black Cactus Global, Inc. unless the context requires otherwise.


Item 1. BUSINESS.


Blockchain Generally


Distributed blockchain technology is a decentralized and encrypted ledger that is designed to offer a secure, efficient, verifiable, and permanent way of storing records and other information without the need for intermediaries. Blockchain technologies are being evaluated for a multitude of industries due to the belief in their ability to have a significant impact in many areas of business, finance, information management, and governance.


Company Overview


We are an early stage technology company focused on developing blockchain software platforms. Our plan is to develop or license intellectual property to build blockchain platforms for a variety of uses. Our initial efforts will focus on utilizing the intellectual property in two ways: to develop secure blockchain based supply chain and inventory control systems, and to develop a blockchain based trading platform in order to facilitate securities trading using either a fiat currency or cryptocurrency.


We plan to develop blockchain based supply chain and inventory control systems that will provide value to businesses across industries by optimizing inventory levels and production targets. For example, distribution companies will be able to utilize the blockchain software platform to control and organize their production and distribution networks. Further, hospital systems will be able to optimize patient care and product supply chains. Our goal in developing a blockchain based trading platform is to make securities trading easier, faster, and safer.


Competition


We expect the Company to compete with other companies that focus all or a portion of their activities on developing programming for the blockchain. At present, the information concerning the activities of these enterprises is not readily available as the vast majority of the participants in this sector do not publish information publicly or the information may be unreliable.  Published sources of information include “bitcoin.org” and “blockchain.info”; however, the reliability of that information and its continued availability cannot be assured. Several public companies (traded in the U.S. and Internationally), such as the following, may be considered to compete with us, although we believe there is no company, including the following, which engages in the same scope of activities as we do.


- 1 -



 

Overstock.com Inc

 

 

 

 

Blockchain Industries, Inc. (formerly Omni Global Technologies, Inc.)

 

 

 

 

DMG Blockchain Solutions

 

 

 

 

Riot Blockchain, Inc.


There is limited available information regarding our potential non-public competitors. The blockchain industry is a highly competitive and evolving industry and new competitors and/or emerging technologies could enter the market and affect our competitiveness in the future.


Government Regulation


We may be subject to a wide variety of laws, rules and regulations, some of which may apply to us as a result of our blockchain business.


Government regulation of blockchain is being actively considered by the United States federal government via several agencies and regulatory bodies, as well as similar entities in other countries. State government regulation also may apply to our activities and other activities in which we participate or may participate in the future.  Regulations may substantially change in the future and it is presently not possible to know how regulations will apply to our business, or when they will be effective. As the regulatory and legal environment evolves, we may become subject to new laws which may affect our activities.


Intellectual Property


As of April 30, 2019, we did not have any intellectual property.  See, Subsequent Events.


Employees


As of April 30, 2019, we had no employees. Our officers provided services to our company on a contract basis as needed.


Corporate Information


We were incorporated in the State of Florida on April 8, 2013, with a fiscal year end of April 30th.  Until June 2017, we had not established any business operations and had not achieved any revenues. Until then, we were in the process of identifying and evaluation feasible business opportunities in the consumer products and technologies industries. On December 4, 2017, the Company changed its name to “Black Cactus Global, Inc.”


A company continues to be deemed an “emerging growth company” until the last day of the fiscal year of the issuer following the fifth anniversary of the date of the first sale of common equity securities of the issuer pursuant to an effective registration statement under the Securities Act of 1933. Our first sale of common equity pursuant to an effective registration statement was during the three months ended October 31, 2013, and last day of the fiscal year of the fifth anniversary of the date of the first sale of our common equity securities was April 30, 2019.  As a result, after April 30, 2019, we were no longer an “emerging growth company”.


Subsequent Events


On August 24, 2019, the Company entered into a Software License Agreement (“License Agreement”) with Charteris, Mackie, Baillie & Cummins Limited (“CMBC Limited”) to acquire a non-exclusive license for Black Cactus blockchain development software platform and related intellectual property (“Software”) which are licensed to CMBC Limited from Black Cactus LLC. As consideration, the Company shall pay CMBC Limited a royalty in the amount of five percent (5%) of the gross revenue received from the sublicense of the Software (“royalty”), due on a quarterly basis, and issue or assign an equivalent number of common shares to CMBC Limited that will represent 60% of the then issued shares of the Company. In addition, the Company will issue an option for CMBC Limited to acquire additional shares at par value ($0.0001) per share up to 60% of any shares issued under the existing Securities Purchase Agreements with Bellridge. The closing of the License Agreement is subject to, among certain other conditions: (1) the Company obtaining a written agreement with Bellridge to increase its line of credit from $1,500,000 to $5,000,000; (2) the resignation of all the directors of the Company serving on the Board, during the quarterly period ended July 31, 2019, which was satisfied by the resignation of all of such directors on September 13, 2019, and the appointment of Lawrence P. Cummins, Karyn Augustinus and three non-executive independent Directors nominated by CMBC Limited; (3) the resignation of all the officers of the


- 2 -



Company serving, during the quarterly period ended July 31, 2019, which was satisfied by the resignation of all of such officers on September 13, 2019, and the appointment of Lawrence P. Cummins as its President (after undertaking a review of the future plans of the Company, the Board of Directors will appoint a Chief Executive Officer); (4) proof satisfactory to CMBC Limited that fair resolutions have been entered into with certain persons, including Harpreet Sangha, the former Chairman of the Board and Chief Financial Officer of the Company, along with his family and known associates for the cancellation of the shares of the Company currently owned by them; (5) CMBC Limited is satisfied with the possibility of lifting the Cease Trade Order issued by the British Columbia Securities Commission on May 6, 2016, to the Company, ordering all persons to cease trading in the Company’s securities until the Company files the required records completed in accordance with the Securities Act, R.S.B.C. 1996 and the Executive Director revokes the Order; (6) the cancellation of $350,000 amount allegedly outstanding under the terms of the Definitive Acquisition Agreement, dated as of June 18, 2017, between the Company and the selling shareholders of BitReturn.ca; (7) repayment by the majority shareholder of the Company of $169,729 owed by such shareholder to the Company; and (8) the Company’s becoming current in its periodic filing with the SEC.


On November 15, 2019, the Company entered into an Assignment Agreement with CMBC Limited to acquire the assignment of a non-exclusive software license (“License”) for Software from Benchmark Advisors Limited (“Benchmark”(the “Assignment Agreement”). As consideration for the assignment of the License, CMBC Limited will be paid $250,000 directly from Bellridge on behalf of the Company as part of the increased line of credit of $5,000,000. The closing of the Assignment Agreement is subject to the same conditions required to be satisfied for consummation of the License Agreement.


Item 1A. Risk Factors.


We are not required to provide the information required by this Item 1A as we are a smaller reporting company.


Item 1B. Unresolved Staff Comments.


None.


Item 2. Properties.


For the year ended April 30, 2019, we required only limited office space for the administration of our business. For the year ended April 30, 2019, Mr. Sangha, an officer and director of the company provided us office space, free of charge at his office.


Item 3. Legal Proceedings.


None.


Item 4. Mine Safety Disclosures


Not applicable.


Part II


Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.


Our Common Stock was quoted on the OTC Pink Sheets, which is sponsored by OTC Markets Group, Inc. The OTC Pink Market is a network of security dealers who buy and sell stock. The dealers are connected by a computer network that provides information on current “bids” and “asks,” as well as volume information. Our shares are quoted on the OTC Pinks under the symbol “BLGI.”


Holders


As of April 30, 2019, there were approximately 31 holders of record of our common stock.  This number does not include shares of common stock held by brokerage clearing houses, depositories or others in unregistered form.


Dividend Policy


To date, we have not paid dividends on shares of our common stock and we do not expect to declare or pay dividends on shares of our common stock in the foreseeable future. The payment of any dividends will depend upon our future earnings, if any, our financial condition, and other factors deemed relevant by our Board of Directors.


- 3 -



Item 6. Selected Financial Data.


We are not required to provide the information required by this Item 6 as we are a smaller reporting company.


Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.


Company Overview


We were incorporated in the State of Florida on April 8, 2013, with a fiscal year end of April 30. Until June 2017, we had not established any business operations and had not achieved any revenues. Until then, we were in the process of identifying and evaluating feasible business opportunities in the consumer products and technology industries.  Currently, the Company is evaluating the development of a technology business in digital currency applications and mining.


Results of Operations


The following discussion of the Company’s financial condition and the results of operations should be read in conjunction with the Financial Statements and Notes thereto appearing elsewhere in this document.


Results of Operations


There is no historical financial information about us upon which to base an evaluation of our performance. We have incurred losses of $4,294,852 and $5,988,299 in our operations for the years ended April 30, 2019 and 2018, respectively.


We did not generate any revenues from our operations for the years ended April 30, 2019 or 2018. We cannot guarantee we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including the financial risks associated with the limited capital resources currently available to us for the implementation of our business strategies.


Since inception, the majority of our time has been spent refining its business plan and preparing for a primary financial offering.


Our results of operations are summarized below:


 

 

For the Year Ended April 30, 2019

 

For the Year Ended April 30, 2018

 

Revenue

 

 

 

 

 

Operating Expenses

 

$

2,241,840

 

$

5,105,930

 

Net Loss and Comprehensive Loss

 

$

(4,294,852

)

$

(5,988,299

)

Net Loss per Share - Basic and Diluted

 

 

(0.02

)

 

(0.05

)

Weighted Average Number Shares Outstanding - Basic and Diluted

 

 

194,033,844

 

 

124,267,460

 


Operating Expenses


We had operating expenses for the year ended April 30, 2019 of $2,241,840 compared to operating expenses of $5,105,930 for the year ended April 30, 2018, which reflects a reduction in operating expenses of $2,864,090 between those two periods.  The reason for this substantial reduction in operating expenses was as a result of our significant expenditures, during the year ended April 30, 2018 on consulting fees ($2,290,710) and website development costs ($2,349,566), which we did not incur during the year ended April 30, 2019. These reductions were partially offset by the recognition of stock-based compensation expense during the year ended April 30, 2019 of $1,875,000.


Net Loss and Comprehensive Loss


We had net loss and comprehensive loss for the year ended April 30, 2019 of $4,294,852 compared to net loss and comprehensive loss of $5,988,299, which reflects a reduction in net loss and comprehensive loss of $1,693,447 between those two periods.  The reason for this substantial reduction in net loss and comprehensive loss was a result of our significant expenditures during the year ended April 30, 2018 on consulting fees ($2,290,710) and website development costs ($2,349,566), partially offset by an increase in accretion of discounts on convertible debentures ($972,750) during the year ended April 30, 2019 compared to 2018 ($44,791) and the recognition of stock-based compensation expense during the year ended April 30, 2019 of $1,875,000.


- 4 -



Management’s Plan of Operation


We do not have adequate funds to satisfy our working capital requirements for the next twelve months. We have borrowed a total of $1,000,000 from Bellridge Capital LP (“Bellridge”) to fund our planned plan of operations in digital currency mining. We sold Bellridge our Senior, Secured Convertible Promissory Notes (the “Notes”).  Thus far, Bellridge has purchased $1,000,000 in Notes. Pursuant to the terms of our agreements with Bellridge, we were required to file a registration statement with the SEC to register the shares of Common Stock to be issued under those agreements. We filed the registration statement on April 24, 2018 but it has not yet been declared effective. We may not receive the fourth and final tranche of $500,000 unless and until the registration statement is declared effective by the SEC. We cannot estimate when our registration statement will be declared effective by the SEC. Under certain conditions, Bellridge may not have to purchase the fourth Note.  These conditions include any acts constituting default under any of the Notes or the agreements entered into at the time of the first purchase of the Note issued on November 27, 2017.  Until such time as we receive the final $500,000 of funding from Bellridge, in the interim, we may not be able to completely implement and commence our proposed plan of operations.


As of April 30, 2019, we had not yet had any revenues from our services in the digital currency mining field.


Liquidity and Capital Resources


As of April 30, 2019, we had not generated any revenues from our business operations. As at April 30, 2019, there were 166,073,296 shares of common stock issued and outstanding. Total cash proceeds received from common share issuance since inception to April 30, 2019 is $90,500.


As of April 30, 2019, we had no cash on hand compared to $252 as of April 30, 2018. As of April 30, 2019, we had a working capital deficiency of $2,352,884 and an accumulated deficit of $10,485,728 compared to $415,940 and $6,190,876, respectively as of April 30, 2018.  Our cash is not sufficient to meet the obligations associated with being a company that is fully reporting with the SEC. We believe we will require additional financing in the form of share issuance proceeds or advances from our directors.  We also may sell additional secured, convertible promissory notes.


Our business expansion will require significant capital resources that may be funded through the issuance of common stock or of notes payable or other debt arrangements that may affect our debt structure. Despite our current financial status, we believe that we may be able to issue notes payable or debt instruments in order to start executing our business plan. However, there can be no assurance that we will be able to raise money in this fashion and have not entered into any agreements that would obligate a third party to provide us with capital.


During the year ended April 30, 2019, we spent $4,294,852 on general and administrative operating expenses. We relied on loans to fund general and administrative operating expenses. As of April 30, 2019, we had no working capital.


As of April 30, 2019, the Company had no external sources of liquidity such as arrangements with credit institutions or off-balance sheet arrangements that will have or are reasonably likely to have a current or future effect on our financial condition or immediate access to capital.


Our independent auditor has expressed substantial doubt about our ability to continue as a going concern and believes that our ability is dependent on our ability to implement our business plan, raise capital and generate revenues. See Note 2 of our financial statements.


Off-Balance Sheet Arrangements


The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect or change on the Company’s financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the Company is a party, under which the Company has (i) any obligation under a guarantee contract that has any of the characteristics identified in FASB ASC paragraph 460-10-15-4 (Guarantees Topic), as may be modified or supplemented, and that is not excluded from the initial recognition and measurement provisions of FASB ASC paragraphs


- 5 -



460-10-15-7, 460-10-25-1, and 460-10-30-1; (ii) a retained or contingent interest in assets transferred to an unconsolidated entity or similar arrangement that serves as credit, liquidity or market risk support to such entity for such assets; (iii) any obligation, including a contingent obligation, under a contract that would be accounted for as a derivative instrument, except that it is both indexed to the registrant’s own stock and classified in stockholders’ equity in the registrant’s statement of financial position, and therefore excluded from the scope of FASB ASC Topic 815, Derivatives and Hedging, pursuant to FASB ASC subparagraph 815-10-15-74(a), as may be modified or supplemented; or (iv) any obligation, including a contingent obligation, arising out of a variable interest (as defined in the FASB ASC Master Glossary), as may be modified or supplemented) in an unconsolidated entity that is held by, and material to, the registrant, where such entity provides financing, liquidity, market risk or credit risk support to, or engages in leasing, hedging or research and development services with, the registrant.


Critical Accounting Policies


See “Footnotes” section to the financial statements for a complete summary of the significant accounting policies used in the presentation of our financial statements. The summary is presented to assist the reader in understanding the financial statements. The accounting policies used conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Because of our election to not opt out of the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the JOBS Act, our financial statements may not be comparable to companies that comply with public company effective dates.


Concentrations, Risks, and Uncertainties


The Company did not have a concentration of business with suppliers or customers constituting greater than 10% of the Company’s gross sales during the reporting period.


Stock Based Compensation


For purposes of determining the variables used in the calculation of stock compensation expense under the provisions of FASB ASC Topic 505, “Equity” and FASB ASC Topic 718, “Compensation — Stock Compensation,” management would perform an analysis of current market data and historical company data to calculate an estimate of implied volatility, the expected term of the option and the expected forfeiture rate. With the exception of the expected forfeiture rate, which is not an input, management uses these estimates as variables in the Black-Scholes option pricing model. Depending upon the number of stock options granted, any fluctuations in these calculations could have a material effect on the results presented in the Company’s statement of operations and other comprehensive income. In addition, any differences between estimated forfeitures and actual forfeitures could also have a material impact on the Company’s financial statements.


Recently Issued Accounting Standards:


The Company has implemented all new mandatory accounting pronouncements that are in effect and there has been no significant impact on its financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.


Item 7A. Quantitative and Qualitative Disclosures About Market Risk.


We are not required to provide the information required by this Item 7A as we are a smaller reporting company.


Item 8. Financial Statements and Supplementary Data.


The financial statements required by this Item 8 are included at the end of this Annual Report on Form 10-K beginning on page F-1.


Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.


None.


- 6 -



Item 9A. Controls and Procedures.


Evaluation of Disclosure Controls and Procedures


We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act that are designed to ensure that information required to be disclosed in our reports filed or submitted to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and that information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of disclosure controls and procedures as of April 30, 2019 pursuant to Rule 13a-15(b) under the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective to ensure that information required to be included in our periodic SEC filings is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms.


Management’s Annual Report on Internal Control over Financial Reporting


Our management is responsible for the preparation of our consolidated financial statements and related information. Management uses its best judgment to ensure that the consolidated financial statements present fairly, in material respects, our financial position and results of operations in conformity with generally accepted accounting principles. Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in the Exchange Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate and that the judgments inherent in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls including the possibility of human error and overriding of controls. Consequently, an effective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.


Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts and expenditures of company assets are made in accordance with our management and directors authorization; and (iii) provide reasonable assurance regarding the prevention of or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.


Under the supervision of management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework (2013 framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission and subsequent guidance prepared by the Commission specifically for smaller public companies. Based on that evaluation, our management concluded that our internal control over financial reporting was not effective as of April 30, 2019, primarily as a result of the fact that, as of April 30, 2019, we had limited resources, including the absence of a financial staff with accounting and financial expertise.


To the extent reasonably possible, given our limited resources, our goal is to bring on additional financial staff and expand our current board of directors to include additional individuals willing to perform directorial functions. Since the recited remedial actions will require that we hire or engage additional personnel, this material weakness may not be overcome in the near term due to our limited financial resources. Until such remedial actions can be realized, we will continue to rely on the advice of outside professionals and consultants.


This Report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm as we are neither an accelerated filer nor a large accelerated filer and are not required to provide the report.


Changes in Internal Control over Financial Reporting


There have been no changes in our internal controls over financial reporting that occurred during the year ended April 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


Item 9B. Other Information.


None.


- 7 -



Part III


Item 10. Directors, Executive Officers and Corporate Governance.


Officers and Directors


Our directors will serve until their successors are elected and qualified. Our officers are appointed by the board of directors to a term of one year and serve until their successor is duly appointed, or until they are removed from office. The board of directors has no nominating, auditing or compensation committees.


The name, address, age and position of our president, secretary/treasurer, directors and vice president is set forth below:


NAME

 

AGE

 

POSITION(S)

 

Date of Appointment or Election

 

 

 

 

 

 

 

Harpreet Sangha

 

54

 

Chairman of the Board, Chief Financial Officer

 

April 14, 2014

 

 

 

 

 

 

 

Dr. Ravindranath Kancherla

 

64

 

Director

 

December 11, 2017

 

 

 

 

 

 

 

Dr. Pruthvinath Kancherla

 

35

 

Director

 

December 11, 2017

 

 

 

 

 

 

 

Dr. Ramesh Para

 

46

 

Chief Executive Officer, Director

 

December 11, 2017


Business Experience


Harpreet Sangha


Mr. Sangha has been the Chairman and Chief Financial Officer of Black Cactus Global, Inc., since April 14, 2014. He has been a founder, CEO and board member of several public companies and has over 30 years of entrepreneurial, operational and capital market experience. In 1986, he started his career as Investment Advisor. Mr. Sangha departed this position in March 2006 and founded Douglas Lake Minerals, where he served as CEO. Mr. Sangha also served as CEO, Secretary, and director of Sharprock Resources Inc. (OTCBB: SHRK), where he raised capital to explore a preproduction gold project in the Chukotka Region of Russia. He also served as Chairman of the Board and Chief Executive Officer of Rango Energy, Inc.


Dr. Ravindranath Kancherla


Dr. Ravindranath Kancherla has served as a director of the Company, since December 2017.  Dr. Kancherla is a practicing Gastrointestinal Endosurgeon and a Fellow of both the Royal College of Surgeons of Edinburgh and Glasgow.  He is the founder of Global Hospitals Group, India’s first multi-organ transplant center where has served as chairman since 2006.  Dr. Kancherla became a Fellow of the Royal College of Surgeons of Edinburgh and the Royal College of Surgeons of Glasgow in 1985.  Dr. Kancherla received his Master of Science from Madras University in 1984 and was granted his Bachelor of Medicine / Bachelor of Surgery in 1980 from Sri Venkateswara Medical College, in Tirupati, AP, India.


Dr. Pruthvinath Kancherla


Dr. Pruthvinath Kancherla has served as a director of the Company since December 11, 2017.  He currently serves as a director of Global Hospitals Group, a multi super specialty tertiary care multi organ transplant facility with facilities in four major metro cities in India. Dr. Kancherla is a medical doctor by trade who also has a Masters in Hospital Administration.


Dr. Ramesh Para


Dr. Ramesh Para has served as Chief Executive Officer of the Company, since December 11, 2017. Since December 2011, Dr. Para has also served as a director of Sysveda UK Limited, where he is responsible for the support of an in-house back office system, incident investigation and for defining functionalities for one of Sysveda’s clients. He coordinates the offshore development team of 350 employees during development, planning user acceptance testing and system code review for the same client. Dr. Para has over 17 years in IT management and development. Dr. Para has a PhD in Management Information Systems, a Master’s in Business Administration and a Bachelor’s of Technology in Computer Science.


- 8 -



Family Relationships


Dr. Ravindranath Kancherla and Dr. Pruthvinath Kancherla are father and son.  There are no other family relationships between any of our directors or executive officers.


Board of Directors


The Board of Directors (“Board”) oversees our business affairs and monitors the performance of our management. In accordance with our corporate governance principles, the Board does not involve itself in day-to-day operations. The directors keep themselves informed through discussions with the Chief Executive Officer, other key executives and by reading the reports and other materials sent to them and by participating in Board and committee meetings. Our directors hold office until the next Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal, or if for some other reason they are unable to serve in the capacity of director.


Our Board currently consists of four (4) members: Hapreet Sangha, Dr. Ravindranath Kancherla, Dr, Pruthvinath Kancherla and Dr. Ramesh Para. All of our directors will serve until our next Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal.


Director Independence


Until April 2018, we had two independent directors, Dr. Ravindranath Kancherla and Dr, Pruthvinath Kancherla, but their status, as independent directors, may have changed, thereafter, as a result of the issuance of 12,500,000 shares of the Company’s common stock to each of them in April 2018, as compensation for services unrelated to their services as directors of the Company.  See, Certain Relationships and Related Transactions.  Because our Common Stock is not currently listed on a national securities exchange, we have used the definition of “independence” of The NASDAQ Stock Market to make this determination. NASDAQ Listing Rule 5605(a)(2) provides that an “independent director” is a person other than an officer or employee of the company or any other individual having a relationship, which in the opinion of the Company’s Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The NASDAQ listing rules provide that a director cannot be considered independent if:


 

the director is, or at any time during the past three years was, an employee of the company;

 

 

 

 

the director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including, among other things, compensation for Board or Board committee service);

 

 

 

 

a family member of the director is, or at any time during the past three years was, an executive officer of the company;

 

 

 

 

the director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity to which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exclusions);

 

 

 

 

the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three years, any of the executive officers of the company served on the compensation committee of such other entity; or

 

 

 

 

the director or a family member of the director is a current partner of the company’s outside auditor, or at any time during the past three years was a partner or employee of the company’s outside auditor, and who worked on the company’s audit.


Annual Meeting Attendance


The Company did not hold an Annual Meeting of Stockholders during the year ended April 30, 2019.


Stockholder Communications with the Board


Stockholders wishing to communicate with the Board, the non-management directors, or with an individual Board member may do so by writing to the Board, to the non-management directors, or to the particular Board member, and mailing the correspondence to: c/o Jeremy Towning, Chief Financial Officer, Black Cactus Global, Inc., 8275 S. Eastern Avenue, Suite 200, Las Vegas, NV, 89123. The envelope should indicate that it contains a stockholder communication. All such stockholder communications will be forwarded to the director or directors to whom the communications are addressed.


- 9 -



Board Committees


Audit Committee


Our Board has not yet formed a separate standing audit committee, as a result of the limited operations of the Company, to date.  To date, our entire Board has performed the functions of an audit committee.  Even if Dr. Ravindranath Kancherla and Dr. Pruthvinath Kancherla are considered to be independent directors, the functions of the audit committee have not been carried out by a majority of independent directors, as Harpreet Sangha, our Chief Financial Officer and Dr Ramesh Para are both executive officers of the Company and, therefore, not considered to be independent directors.  As provided above, the status of Drs. Kancherla, as independent directors, may have changed, during the year ended April 30, 2018, as a result of the issuance of 12,500,000 shares of the Company’s common stock to each of them in April 2018, as compensation for services unrelated to their services as directors of the Company.  See, Certain Relationships and Related Transactions.  Additionally, none of our directors is considered an “audit committee financial expert” as defined in Item 5(a)(ii) and (iii) of Regulation S-K.  Mr. Sangha has performed the type of services that would normally be provided by an “audit committee financial expert,” based on his financial background, which includes 30 years of experience in the brokerage industry.  Audit committee functions include:


 

selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;

 

 

 

 

helping to ensure the independence and performance of the independent registered public accounting firm;

 

 

 

 

discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent registered public accounting firm, our interim and year-end operating results;

 

 

 

 

reviewing our policies on risk assessment and risk management;

 

 

 

 

reviewing related party transactions;

 

 

 

 

obtaining and reviewing a report by the independent registered public accounting firm at least annually, that describes our internal control procedures, any material weaknesses with such procedures, and any steps taken to deal with such material weaknesses when required by applicable law; and

 

 

 

 

approving (or, as permitted, pre-approving) all audit and all permissible non-audit services, other than de minimis non-audit services, to be performed by the independent registered public accounting firm.


We intend to establish a separate standing audit committee comprised of independent directors and appoint an “audit committee financial expert” to that committee, as soon as the Company commences more than limited business operations.


Compensation Committee


Our Board has not yet formed a separate standing compensation committee, as a result of the limited operations of the Company, to date. To date, our entire Board has performed the functions of a compensation committee.  For the same reasons as provided above relating to audit committed functions, compensation committee functions have not been carried out by a majority of independent directors.  Dr. Ravindranath Kancherla and Pruthvinath Kancherla are the directors who participate in the consideration of executive officer and director compensation, as they are the two directors of the Company who do not serve as executive officers of the Company, although, as previously provided, it is possible that neither of them may be considered independent directors.  Compensation committee functions include:


 

reviewing and approving the compensation of our executive officers;

 

 

 

 

reviewing the compensation of our directors;

 

 

 

 

reviewing the terms of compensatory arrangements with our executive officers;

 

 

 

 

administering our stock and equity incentive plans;

 

 

 

 

reviewing incentive compensation and equity plans; and

 

 

 

 

reviewing and establishing general policies relating to compensation and benefits of our employees and reviewing our overall compensation philosophy.


- 10 -



We intend to establish a separate standing compensation committee comprised of independent directors, as soon as the Company commences more than limited business operations.


Nominating Committee and Corporate Governance Committee


Our Board has not yet formed a separate standing compensation committee, as a result of the limited operations of the Company, to date.  To date, our entire Board has performed the functions of a compensation committee.  For the same reasons as provided above relating to audit committed functions, functions relating to nominating and corporate governance have not been carried out by a majority of independent directors.  Dr. Ravindranath Kancherla and Pruthvinath Kancherla are the directors who participate in the consideration of nominating and governance procedures, as they are the two directors of the Company who do not serve as executive officers of the Company, although, as previously provided, it is possible that neither of them may be considered independent directors. When considering whether directors and nominees have the experience, qualifications, attributes and skills, taken as a whole, to enable the Board of Directors to satisfy its oversight responsibilities effectively in light of the Company’s business and structure, the Board of Directors focuses primarily on each person’s background and experience as reflected in the information discussed in each of the directors’ individual biographies set forth above. We search for directors who possess relevant knowledge and experience in the finance, accounting and business fields generally.  These functions also include:


 

Identifying, evaluating and selecting nominees for election to our Board;

 

 

 

 

evaluating the performance of our Board and of individual directors;

 

 

 

 

considering the composition of our Board;

 

 

 

 

reviewing developments in corporate governance practices;

 

 

 

 

evaluating the adequacy of our corporate governance practices and reporting;

 

 

 

 

developing corporate governance guidelines and matters; and

 

 

 

 

overseeing an annual evaluation of the Board’s performance.


We intend to establish a separate standing compensation committee comprised of independent directors, as soon as the Company commences more than limited business operations.


Code of Ethics


The Board adopted a Code of Ethics for the Company on April 8, 2013. We require all employees, directors and officers, including our principal executive officer and principal financial officer to adhere to the Code of Ethics in addressing legal and ethical issues encountered in conducting their work. The Code of Ethics requires that these individuals avoid conflicts of interest, comply with all laws and other legal requirements, conduct business in an honest and ethical manner and otherwise act with integrity and in our best interest. The Code of Ethics contains additional provisions that apply specifically to our Chief Executive Officer, Chief Financial Officer and other finance department personnel with respect to full and accurate reporting.


Delinquent Section 16(a) Reports


Section 16(a) of the Exchange Act requires the Company’s directors and executive officers, and persons who own more than ten percent (10%) of the Common Stock, to file with the SEC the initial reports of ownership and reports of changes in ownership of Common Stock. Officers, directors and greater than ten percent (10%) stockholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file. Specific due dates for such reports have been established by the SEC, and the Company is required to disclose in this Proxy Statement any failure to file reports by such dates during fiscal year ended April 30, 2019. Based solely on its review of the copies of such reports received by it, or written representations from certain reporting persons that no Forms 5 were required for such persons, the Company believes that during the fiscal year ended April 30, 2019, there was no failure to comply with Section 16(a) filing requirements applicable to its executive officers, directors or greater than ten percent (10%) stockholders other than as listed in the table below:


- 11 -



Name

 

Number
of Late
Reports

 

Description

Dr. Ravindranath Kancherla

 

1

 

1 transaction was not reported on a timely basis upon the acquisition of Common Stock.

 

 

 

 

 

Dr. Pruthvinath Kancherla

 

1

 

1 transaction was not reported on a timely basis upon the acquisition of Common Stock.

 

 

 

 

 

Dr. Ramesh Para

 

1

 

1 transaction was not reported on a timely basis upon the acquisition of Common Stock.


Item 11. Executive Compensation.


Summary Compensation Table


The table below summarizes all compensation awarded to, earned by, or paid to each named executive officer for our last two completed fiscal years for all services rendered to us.


SUMMARY COMPENSATION TABLE

Name and
principal
position

 

Year

 

Salary
($)

 

Bonus
($)

 

Stock
Awards
($)

 

Option
Awards
($)

 

Non-Equity
Incentive Plan
Compensation
($)

 

Nonqualified
Deferred
Compensation
Earnings
($)

 

All Other
Compensation
($)

 

Total
($)

Harpreet Sangha,

 

2019

 

0

 

0

 

0

 

0

 

0

 

0

 

0

 

0

CFO

 

2018

 

0

 

0

 

0

 

0

 

0

 

0

 

0

 

0

Dr. Ramesh Para,

 

2019

 

0

 

0

 

468,750

 

0

 

0

 

0

 

0

 

468,750

CEO

 

2018

 

0

 

0

 

0

 

0

 

0

 

0

 

0

 

0


We do not have employment agreements with any of our executive officers. We also do not have pension, health, annuity, insurance, stock options, profit sharing, or similar benefit plans. However, we may adopt plans in the future.


Employment Agreements


We do not have employment agreements with any of our executive officers.


Outstanding Equity Awards At Fiscal Year-end Table


At the end of our last completed fiscal year, our named executive officers did not have any outstanding unexercised options, stock that have not vested, or equity incentive plan awards.


Compensation of Directors


Our directors did not receive any compensation for their services as a director of the Company. We do not have compensation agreements with any of our directors.


Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.


The following table sets forth certain information regarding the beneficial ownership of our common stock as of April 30, 2019 by (a) each shareholder who is known to us to own beneficially 5% or more of our outstanding common stock; (b) all directors; (c) our executive officers; and (d) all executive officers and directors as a group. Except as otherwise indicated, all persons listed below have (i) sole voting power and investment power with respect to their shares of common stock, except to the extent that authority is shared by spouses under applicable law, and (ii) record and beneficial ownership with respect to their shares of common stock.


For purposes of this table, a person or group of persons is deemed to have “beneficial ownership” of any shares of common stock that such person has the right to acquire within sixty (60) days of April 30, 2019. For purposes of computing the percentage of outstanding shares of our common stock held by each person or group of persons named above, any shares that such person or persons has the right to acquire within sixty (60) days of April 30, 2019 is deemed to be outstanding, but is not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed as beneficially owned does not constitute an admission of beneficial ownership. Unless otherwise identified, the address of our directors and executive officers is c/o Black Cactus Global, Inc., 8275 S. Eastern Avenue, Suite 200, Las Vegas, Nevada 89123.


- 12 -



Name and Address of Shareholders

 

Amount and Nature of
Shareholders Ownership

 

Percent
of Class

 

 

 

 

 

 

 

5% or greater shareholders

 

 

 

 

 

 

 

 

 

 

 

Sai Krishna Para (1)

 

12,500,000

 

7.53%

 

 

 

 

 

 

 

Directors and executive officers (2)

 

 

 

 

 

 

 

 

 

 

 

Harpreet Sangha

 

23,200,000

 

13.96%

 

 

 

 

 

 

 

Dr. Ravindranath Kancherla

 

12,500,000

 

7.53%

 

 

 

 

 

 

 

Dr. Pruthvinath Kancherla

 

12,500,000

 

7.53%

 

 

 

 

 

 

 

Dr. Ramesh Para

 

12,500,000

 

7.53%

 

 

 

 

 

 

 

All officers and directors as a group (4 persons)

 

60,700,000

 

36.66%

 

__________

(1)

The principal business address of this reporting person is 14 Colvin Road, London E6 1JL.

 

 

(2)

The principal business address of all executive officers and directors is c/o Black Cactus Global, Inc., 8275 S. Eastern Avenue #200, Las Vegas, NV 89123.


Item 13. Certain Relationships and Related Transactions, and Director Independence.


Certain Relationships and Related Transactions


Except as described below, other than compensation arrangements, during the past two fiscal years, there have been no transactions, whether directly or indirectly, between us and any of our officers, directors, beneficial owners of more than 5% of our outstanding Common Stock or their family members that exceeded the lesser of (i) $120,000 or (ii) one percent (1%) of the average of our total assets at year end.


During the year ended April 30, 2019, The Company made payments totaling $339,554 related to expenses overseen by Mr. Harpreet Sangha the former CFO, President and Chairman of the Board. The Company has not been provided invoices or other support for the expenses. The Company intends to recover the full amount of $339,554, from the former CFO, President and Chairman of the Board, however ultimate collection is uncertain as at April 30, 2019 and the full amount has been written off as uncollectible expense recovery.


As at April 30, 2019, the Company has a balance due from related parties, net of allowances for uncollectible receivables, of $Nil (2018 - $327,541). The amount is unsecured, non-interest bearing and due on demand.


On June 22, 2017, the Company entered into a secured loan with a corporation with a significant shareholder for a loan up to CAD$450,000 for the purpose of purchasing digital currency mining hardware (“Mining Hardware”). The loan was non-interest bearing and due on August 31, 2017. The Mining Hardware purchased with the loaned funds was held as collateral until the loan amount had been fully repaid.  As at September 30, 2017, the Company had not made the required payment of the loan and the Lender took sole possession of the Mining Hardware.


During the year ended April 30, 2019, the Company incurred $28,000 (2018 - $228,000) in consulting fees from a former officer and a former director of the Company. As of April 30, 2019, the Company has included in accounts payable $117,800 (2018 - $89,800) due to these parties.


- 13 -



On October 30, 2018, an aggregate of 50,000,000 shares of our common stock, which were issued in certificated form on April 27, 2018, in the amounts of 12,500,000 each to our directors Dr. Pruthvinath Kancherla, Dr. Ravindranath Kancherla Dr. Ramesh Para, and to Sai Krishna Para, the nephew of Dr. Ramesh Para, were transferred into book entry form. These shares of common stock were issued to them in consideration for their services to be performed, in connection with our proposed acquisition of 29% of the outstanding common stock of Black Cactus Global Technologies Pvt. Limited (“BCGT”), a corporation organized under the laws of India, the CEO of which is Dr. Ramesh Para, the CEO of the Company, and were to be cancelled if the acquisition was not consummated.  On October 24, 2018, we received notice from the applicable regulators, in India, that they would not approve our acquisition of the shares of common stock of BCGT.  As a result, the transaction was never consummated.  The 50,000,000 shares of our common stock issued to our three directors and Sai Krishna Para were to be cancelled as a result of the failure to consummate the acquisition of the shares of common stock of BCGT, but such shares have not yet been cancelled and continue to be issued and outstanding shares of common stock of the Company.


At April 30, 2019, the Company was indebted for loans amounting to $500 (2018 - $500). The amounts are unsecured, non-interest bearing and due on demand.


On September 15, 2017, the Company entered into a loan agreement with a principal balance of $500,000 with an unrelated third party.  The loan was subject to interest at 10% and due on April 30, 2018.  On April 30, 2018, the Company issued 10,630,000 shares of common stock with a fair value of $1,275,600 to settle the $500,000 of principal and $31,250 of interest owed under the loan agreement.  The Company recorded a loss on settlement of debt upon settlement of $744,350.


On February 14, 2018, the Company entered into a loan agreement for a principal balance of $25,000. The loan bears interest at 10% per annum and was due on February 13, 2019. The loan remains unpaid at April 30, 2019.


On April 23, 2018, the Company entered into a loan agreement for a principal balance of $15,000. The loan bears interest at 10% per annum and was due on May 15, 2018. The loan was repaid during the year ended April 30, 2019.


On September 30, 2017, the Company entered into a loan agreement for a principal balance of $130,000.  The loan was subject to interest at 10% per annum and due on April 30, 2018. On May 24, 2018, the Company issued 2,600,000 shares of common stock to settle the $130,000 of principal and $6,500 of interest owing under the loan agreement (refer to Note 14). The fair value of the shares issued was determined to be $338,000, and as a result, the Company recorded a loss on settlement of debt of $201,500 during the year ended April 30, 2019.


On November 27, 2017, the Company sold its Note for $500,000 to Bellridge and issued Bellridge 2,793,296 shares of the Company’s common stock as a commitment fee.  The Company also issued Bellridge 7,894,737 warrants to purchase the underlying shares of common stock.  The warrants were to be issued six months after closing of the first Note or May 27, 2018 and have a term of four years.  The warrants are exercisable at the lower of $0.10 per share or seventy percent (70%) of the lowest traded price of the Company’s common stock during the prior twenty consecutive trading days, subject to adjustments.  On December 20, 2017, Bellridge advanced an additional $300,000 to the Company and the Company issued its second Note for $300,000 on April 5, 2018. The first Note was due November 27, 2018 and  the second Note was due on December 20, 2018.  On June 1, 2018, Bellridge advanced an additional $200,000 to the Company and the Company issued its third note for $200,000 which was due on June 1, 2019. All Notes accrue interest at five percent (5%) on an annual basis and may be converted into shares of the Company’s common stock at the lower of $0.10 per share or seventy percent (70%) of the lowest traded price of the Company’s common stock during the prior twenty consecutive trading days, subject to adjustments.


In April, 2018, we issued Bellridge three warrants for an aggregate 85 million shares of common stock with an exercise price of $0.10 for a period of four years.  We also issued a warrant to purchase 560,717 of our common stock at $0.10 per share for a period of four years to our financial advisor in connection with the Bellridge transactions.


As part of the Bellridge Agreements, we also executed Registration Rights Agreement, Intellectual Property Security Interest Agreement, Subsidiary Guaranty and a Security Interest Agreement in all the Company’s assets to Bellridge.


As of April 30, 2019, the Company defaulted on the Notes, resulting in the Notes becoming immediately due and payable. Upon default, the interest rate increased to 29% per annum and the Company incurs a late fee at an interest rate equal to 18% per annum on any overdue and unpaid interest under the convertible note. Additionally, the total amount owed on the convertible note upon default is equal to 130% of the outstanding principal and accrued and unpaid interest.


- 14 -



Item 14. Principal Accountant Fees and Services.


The following table shows what the auditor billed for the audit and other services for the years ended April 30, 2019 and 2018.


 

Year Ended
April 30, 2019

 

Year Ended
April 30, 2018

 

 

 

 

 

 

 

 

Audit Fees

$

41,300

 

$

60,725

 

Audit-Related Fees

 

 

 

 

Tax Fees

 

5,750

 

 

3,750

 

All Other Fees

 

 

 

 

Total

$

47,050

 

$

64,475

 


Audit Fees — This category includes the audit of the Company’s annual financial statements, review of financial statements included in the Company’s Form 10-Q Quarterly Reports and services that are normally provided by the independent auditors in connection with engagements for those years.


Audit-Related Fees — N/A


Tax Fees — N/A


Overview — The Company’s Board reviews, and in its sole discretion pre-approves, our independent auditors’ annual engagement letter including proposed fees and all audit and non-audit services provided by the independent auditors. Accordingly, all services described under “Audit Fees,” “Audit-Related Fees,” and “Tax Fees” were pre-approved by our Company’s Board. The Board may not engage the independent auditors to perform the non-audit services proscribed by law or regulation.


Part IV


Item 15. Exhibits and Financial Statement Schedules.


(a) Financial Statements.


Report of Independent Registered Public Accounting Firm

F-2

Balance Sheets

F-3

Statements of Operations and Comprehensive Loss

F-4

Statements of Stockholders’ Deficit

F-5

Statements of Cash Flows

F-6

Notes to the Financial Statements

F-7


(b) Exhibits


Exhibit
Number

 

Description

3.1(i)

 

Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s registration statement on Form S-1 filed with the Commission on May 23, 2013).

3.1(ii)

 

Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.3 to the registrant’s Current Report on Form 8-K filed with the Commission on June 9, 2014).

3.1(iii)

 

Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the Commission on December 1, 2017).

3.2

 

By-Laws (incorporated by reference to Exhibit 3.2 to the registrant’s registration statement on Form S-1 filed with the Commission on May 23, 2013).

4.1

 

Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to the registrant’s registration statement on Form S-1 filed with the Commission on May 23, 2013).

4.2

 

Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

continued


- 15 -



Exhibit
Number

 

Description

4.3

 

Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

4.4

 

Security Agreement (incorporated by reference to Exhibit 4.3 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

4.5

 

Intellectual Property Security Agreement (incorporated by reference to Exhibit 4.4 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

4.6

 

Subsidiary Guarantee Agreement (incorporated by reference to Exhibit 4.5 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

4.7

 

Form of Senior Secured Convertible Promissory Note issued to Bellridge Capital, L.P. in November 2017 (incorporated by reference to Exhibit 4.7 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

4.8

 

Form of Financial Advisory Common Stock Purchase Warrant issued to Aegis Capital Corp. (incorporated by reference to Exhibit 4.8 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

4.9

 

Form of Common Stock Purchase Warrants issued to Bellridge Capital, L.P. in April 2017 (incorporated by reference to Exhibit 4.9 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

4.10 *

 

Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

10.1

 

Definitive Acquisition Agreement dated June 18, 2017 by and among the registrant and the BitReturn shareholders (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the Commission on June 27, 2017).

10.2

 

Securities Purchase Agreement dated November 27, 2017 by and among the registrant and Black Cactus, LLC (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

10.3

 

Registration Rights Agreement dated November 27, 2017 by and among the Registrant and Black Cactus, LLC (incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K filed with the Commission on December 15, 2017)

10.4

 

Amendment to Registration Rights Agreement, dated November 27, 2017 (Amendment dated April 13, 2018) (incorporated by reference to Exhibit 10.4 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

10.5

 

Amendment to Securities Purchase Agreement, dated November 27, 2017 (Amendment dated April 5, 2018) (incorporated by reference to Exhibit 10.5 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

10.6

 

Securities Purchase Agreement, dated April 5, 2018 (incorporated by reference to Exhibit 10.6 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

10.7

 

Registration Rights Agreement, dated April 13, 2018 (incorporated by reference to Exhibit 10.7 to the registrant’s Registration Statement on Form S-1 filed with the Commission on April 24, 2018)

10.8

 

Software License Agreement, dated August 24, 2019, between Charteris, Mackie, Baillie & Cummins Limited and Black Cactus Global, Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report for the quarter ended October 31, 2018)

10.9

 

Assignment Agreement, dated November 15, 2019, between Charteris, Mackie, Ballie & Cummins Limited and Black Cactus Global, Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report for the quarter ended October 31, 2018)

21.1 *

 

Subsidiaries of the Registrant

31.1 *

 

Certification of CEO pursuant to Rule 13a-14(a)/15d-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2 *

 

Certification of CFO pursuant to Rule 13a-14(a)/15d-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1 *

 

Certification of CEO pursuant to 18 U.S.C. Section 1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2 *

 

Certification of CFO pursuant to 18 U.S.C. Section 1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS**

 

XBRL Instance File

101.SCH**

 

XBRL Schema File

101.CAL**

 

XBRL Calculation File

101.DEF**

 

XBRL Definition File

101.LAB**

 

XBRL Label File

101.PRE**

 

XBRL Presentation File

__________

* Filed herewith

** To be submitted by amendment


- 16 -



SIGNATURES


Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



 

Black Cactus Global, Inc.

 

 

 

Date: June 29, 2020

By:

/s/ Jeremy Towning

 

 

Jeremy Towning, Chief Executive Officer



Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.  



Date: June 29, 2020

By:

/s/ Jeremy Towning

 

 

Chief Executive Officer, Chief Financial Officer and Director

(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)


- 17 -



INDEX TO THE FINANCIAL STATEMENTS



Report of Independent Registered Public Accounting Firm

F-2

 

 

Balance Sheets

F-3

 

 

Statements of Operations and Comprehensive Loss

F-4

 

 

Statements of Stockholders’ Deficit

F-5

 

 

Statements of Cash Flows

F-6

 

 

Notes to the Financial Statements

F-7


F-1



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the stockholders and the board of directors of

Black Cactus Global, Inc.


Opinion on the Financial Statements


We have audited the accompanying balance sheets of Black Cactus Global, Inc. (the “Company”) as of April 30, 2019 and 2018, the related statements of operations and comprehensive loss, stockholders’ deficit and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2019 and 2018, and the results of its operations and its cash flows for the years ended then, in conformity with accounting principles generally accepted in the United States of America.


Explanatory Paragraph – Going Concern


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 2 the Company has not generated revenue or cash flow from operations since inception. As at April 30, 2019, the Company has a working capital deficiency of $2,352,884 and an accumulated deficit of $10,485,728. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.


Basis for Opinion


These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.


We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.


Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.



Manning Elliott LLP



Vancouver, British Columbia, Canada


June 29, 2020



We have served as the Company’s auditor since 2015.


F-2



BLACK CACTUS GLOBAL, INC.

BALANCE SHEETS

(Expressed in U.S. Dollars)


 

 

April 30,

 

April 30,

 

 

 

2019

 

2018

 

 

 

 

 

 

 

 

 

ASSETS



 



 


 



 



 


CURRENT ASSETS



 



 


Cash and cash equivalents

 

$

 

$

252

 

Due from related parties (Note 7)

 

 

 

 

327,541

 

Prepaid expenses and other assets (Note 6)

 

 

3,230

 

 

164,020

 

TOTAL ASSETS

 

$

3,230

 

$

491,813

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Accounts payable and accrued liabilities (Note 8)

 

$

573,615

 

$

304,737

 

Amount payable for BitReturn (Note 12)

 

 

350,000

 

 

350,000

 

Convertible debentures (Note 10)

 

 

1,368,423

 

 

44,791

 

Loans payable (Note 9)

 

 

64,076

 

 

208,225

 

Total Liabilities

 

 

2,356,114

 

 

907,753

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value; 10,000,000 shares authorized, of which
10,000 shares designated as Series A, no shares issued and outstanding (Note 14)

 

 

 

 

 

Common stock, $0.0001 par value; 490,000,000 shares authorized;
166,073,296 and 166,673,296 shares issued and 166,073,296 and 113,473,296 shares outstanding as of April 30, 2019 and 2018, respectively (Note 14)

 

 

16,608

 

 

11,347

 

Common stock in treasury, $0.0001 par value; Nil and 53,200,000 shares as of
April 30, 2019 and 2018, respectively (Note 14)

 

 

 

 

1

 

Shares issuable (Note 13(e))

 

 

420,000

 

 

420,000

 

Additional paid-in capital

 

 

7,696,236

 

 

5,343,588

 

Accumulated deficit

 

 

(10,485,728

)

 

(6,190,876

)

Total Stockholders’ Deficit

 

 

(2,352,884

)

 

(415,940

)

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

$

3,230

 

$

491,813

 

 

 

 

 

 

 

 

 

Going concern (Note 2)

 

 

 

 

 

 

 

Commitments (Note 13)

 

 

 

 

 

 

 

Subsequent events (Note 17)



 



 



The accompanying notes are an integral part of these financial statements.


F-3



BLACK CACTUS GLOBAL, INC.

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Expressed in U.S. Dollars)


 

 

For the Year Ended
April 30,

 

 

 

2019

 

2018

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

Consulting (Note 13)

 

$

108,133

 

$

2,290,710

 

General and administrative

 

 

28,602

 

 

122,390

 

Investor relations

 

 

71,333

 

 

105,667

 

Professional fees

 

 

158,772

 

 

237,597

 

Product development and website costs (Note 12)

 

 

 

 

2,349,566

 

Stock-based compensation (Note 14)

 

 

1,875,000

 

 

 

 

 

 

 

 

 

 

 

TOTAL OPERATING EXPENSES

 

$

(2,241,840

)

$

(5,105,930

)

 

 

 

 

 

 

 

 

OTHER EXPENSES

 

 

 

 

 

 

 

Accretion of discounts on convertible debentures (Note 10)

 

 

(972,750

)

 

(44,791

)

Allowance for receivables (Note 7)

 

 

(339,554

)

 

 

Loss on settlement of debt (Note 9(c))

 

 

(201,500

)

 

(744,350

)

Interest expense

 

 

(539,208

)

 

(43,228

)

Write-off on loan advanced

 

 

 

 

(50,000

)

 

 

 

 

 

 

 

 

NET LOSS AND COMPREHENSIVE LOSS

 

$

(4,294,852

)

$

(5,988,299

)

 

 

 

 

 

 

 

 

NET LOSS PER COMMON SHARE, BASIC AND DILUTED

 

$

(0.02

)

$

(0.05

)

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED

 

 

194,033,844

 

 

124,267,460

 


The accompanying notes are an integral part of these financial statements.


F-4



BLACK CACTUS GLOBAL, INC.

STATEMENTS OF STOCKHOLDERS’ DEFICIT

(Expressed in U.S. Dollars)


 

 

 

 

 

 

 

 

 

Additional

 

 

 

Total

 

 

Preferred Stock

 

Common Stock

 

Treasury

 

Shares

 

Paid-in

 

Accumulated

 

Stockholders’

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Amount

 

Issuable

 

Capital

 

Deficit

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance – April 30, 2017

 

$

 

83,000,000

 

$

8,300

 

$

 

$

14,000

 

$

74,559

 

$

(202,577

)

$

(105,718

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount on loan payable

 

 

 

 

 

 

 

 

 

 

 

477

 

 

 

 

477

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for cash

 

 

 

1,400,000

 

 

140

 

 

 

 

(14,000

)

 

13,860

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for services

 

 

 

5,650,000

 

 

565

 

 

 

 

 

 

1,376,434

 

 

 

 

1,376,999

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for domain name

 

 

 

10,000,000

 

 

1,000

 

 

 

 

 

 

1,899,000

 

 

 

 

1,900,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock as part of convertible debt financing

 

 

 

2,793,296

 

 

279

 

 

 

 

 

 

100,553

 

 

 

 

100,832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock to settle loans payable

 

 

 

10,630,000

 

 

1,063

 

 

 

 

 

 

1,274,537

 

 

 

 

1,275,600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beneficial conversion features and warrants associated with convertible debt

 

 

 

 

 

 

 

 

 

 

 

604,168

 

 

 

 

604,168

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issuable for services

 

 

 

 

 

 

 

 

 

420,000

 

 

 

 

 

 

420,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for executive license agreement

 

 

 

60,000,000

 

 

6,000

 

 

 

 

 

 

6,594,000

 

 

 

 

6,600,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancellation of common stock for executive license agreement

 

 

 

(60,000,000

)

 

(6,000

)

 

 

 

 

 

(6,594,000

)

 

 

 

(6,600,000

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Treasury stock

 

 

 

53,200,000

 

 

 

 

1

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,988,299

)

 

(5,988,299

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance – April 30, 2018

 

$

 

166,673,296

 

$

11,347

 

$

1

 

$

420,000

 

$

5,343,588

 

$

(6,190,876

)

$

(415,940

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock to settle loans payable

 

 

 

2,600,000

 

 

260

 

 

 

 

 

 

337,740

 

 

 

 

338,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beneficial conversion features and warrants associated with convertible debt

 

 

 

 

 

 

 

 

 

 

 

144,908

 

 

 

 

144,908

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transfer of treasury stock

 

 

 

 

 

5,000

 

 

 

 

 

 

1,870,000

 

 

 

 

1,875,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancellation of treasury stock

 

 

 

(3,200,000

)

 

1

 

 

(1

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,294,852

)

 

(4,294,852

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance – April 30, 2019

 

$

 

166,073,296

 

$

16,608

 

$

 

$

420,000

 

$

7,696,236

 

$

(10,485,728

)

$

(2,352,884

)


The accompanying notes are an integral part of these financial statements.


F-5



BLACK CACTUS GLOBAL, INC.

STATEMENTS OF CASH FLOWS

(Expressed in U.S. Dollars)


 

 

For the Year Ended
April 30,

 

 

 

2019

 

2018

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Net loss

 

$

(4,294,852

)

$

(5,988,299

)

Adjustments for non-cash amounts expensed:

 

 

 

 

 

 

 

Accretion of loan discounts

 

 

851

 

 

3,918

 

Accretion of convertible debt discount

 

 

972,750

 

 

44,791

 

Accrued interest on debentures

 

 

529,251

 

 

 

Allowance for receivables

 

 

339,554

 

 

 

Issuance of common stock for BitReturn (Note 12)

 

 

 

 

1,900,000

 

Issuance of common shares for services

 

 

 

 

1,297,333

 

Loss on settlement of debt

 

 

201,500

 

 

744,350

 

Shares issuable for services

 

 

 

 

420,000

 

Stock-based compensation

 

 

1,875,000

 

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Prepaid expenses

 

 

160,790

 

 

(84,353

)

Accounts payable and accrued liabilities

 

 

61,917

 

 

298,836

 

 

 

 

 

 

 

 

 

Net Cash Used in Operating Activities

 

 

(153,239

)

 

(1,363,424

)

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

Purchase of equipment (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Cash Used in Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

Advances to related party, net of repayments

 

 

(13,599

)

 

(329,413

)

Proceeds from issuance of convertible debt, net of debt financing costs

 

 

180,000

 

 

705,000

 

Proceeds from (repayments of) loans payable

 

 

(15,000

)

 

637,526

 

Amount payable for BitReturn

 

 

 

 

350,000

 

 

 

 

 

 

 

 

 

Net Cash Provided by Financing Activities

 

 

151,401

 

 

1,363,113

 

 

 

 

 

 

 

 

 

Net effect of exchange rate changes on cash

 

 

1,586

 

 

560

 

 

 

 

 

 

 

 

 

Change in Cash and Cash Equivalents

 

 

(252

)

 

249

 

 

 

 

 

 

 

 

 

Cash and Cash Equivalents, Beginning of Year

 

 

252

 

 

3

 

 

 

 

 

 

 

 

 

Cash and Cash Equivalents, End of Year

 

$

 

$

252

 

 

 

 

 

 

 

 

 

SUPPLEMENTARY CASH FLOW INFORMATION:

 

 

 

 

 

 

 

Interest paid

 

$

 

$

 

Income taxes paid

 

$

 

$

 


The accompanying notes are an integral part of these financial statements.


F-6



1. NATURE OF BUSINESS


Black Cactus Global, Inc. was incorporated in the State of Florida on April 8, 2013. The address of the head office is Suite 200, 8275 South Eastern Avenue, Las Vegas, Nevada 89123. The Company’s plan is to develop a blockchain technology business. On December 4, 2017, the Company changed its name from Envoy Group Corp. to Black Cactus Global, Inc.


2. GOING CONCERN


The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has not generated revenue or cash flow from operations since inception. As at April 30, 2019, the Company has a working capital deficiency of $2,352,884 and an accumulated deficit of $10,485,728. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to raise sufficient financing to acquire or develop a profitable business. The Company intends to finance its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including related party advances and term notes until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.


3. SIGNIFICANT ACCOUNTING POLICIES


BASIS OF PRESENTATION


These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and are expressed in United States dollars. The Company’s fiscal year-end is April 30.


The significant accounting policies followed are:


USE OF ESTIMATES


The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates related to fair value measurements, allowances for doubtful receivables, stock-based compensation and deferred income tax asset valuation allowance. Actual results could differ from those estimates.


FOREIGN CURRENCY TRANSLATION


The Company’s functional and reporting currency is the United States dollar. Occasional transactions may occur in Canadian dollars. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income. The Company has not, to the date of these financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.


FINANCIAL INSTRUMENTS


ASC 825, “Financial Instruments”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 825 prioritizes the inputs into three levels that may be used to measure fair value:


Level 1


Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.


F-7



Level 2


Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.


Level 3


Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.


The financial instruments consist principally of cash and cash equivalents, due from related parties, accounts payable, amount payable, loans payable and convertible debentures. The fair value of cash and cash equivalents when applicable is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. Derivative liabilities are determined based on “Level 2” inputs, which are significant and observable. The Company believes that the recorded values of all other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.


Assets and liabilities measured at fair value on a recurring basis were presented on the Company’s balance sheet as of April 30, 2019 and April 30, 2018:


 

Fair Value Measurements Using

 

 

 

Quoted Prices in

Significant

 

 

 

 

Active Markets

Other

Significant

 

 

 

For Identical

Observable

Unobservable

Balance as of

Balance as of

 

Instruments

Inputs

Inputs

April 30,

April 30,

 

(Level 1)

(Level 2)

(Level 3)

2019

2018

Assets:

 

 

 

 

 

Cash and cash equivalents

$        —

$        —

$        —

$        —

$      252


Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by placing its cash and cash equivalents with high credit quality financial institutions.


CASH AND CASH EQUIVALENTS


All cash investments with an original maturity of three months or less are considered to be cash equivalents.


INCOME TAXES


The Company accounts for income taxes under ASC 740 “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.


NET INCOME (LOSS) PER COMMON SHARE


Net income (loss) per share is calculated in accordance with ASC 260, “Earnings Per Share.” The weighted-average number of common shares outstanding during each period is used to compute basic earning or loss per share. Diluted earnings or loss per share is computed using the weighted average number of shares and diluted potential common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised.


Basic net income (loss) per common share is based on the weighted average number of shares of common stock outstanding. As of April 30, 2019, the Company had 344,082,359 (2018 – 110,641,291) dilutive potential common shares.


F-8



RECENT ACCOUNTING PRONOUNCEMENTS


The Company has implemented all new mandatory accounting pronouncements that are in effect and there has been no significant impact on its financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.


4. FINANCIAL RISK FACTORS


LIQUIDITY RISK


Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at April 30, 2019, the Company has a working capital deficiency of $2,352,884 and requires additional funding to meet its current obligations. The Company’s current obligations include accounts payable and accrued liabilities which have contractual maturities of less than 60 days and are subject to normal trade terms, loans payable which are due on demand, and convertible debts which have defaulted and are due on demand. The ability of the Company to continue to identify and evaluate feasible business opportunities, develop products and generate working capital is dependent on its ability to secure additional equity or debt financing.


FOREIGN EXCHANGE RISK


Foreign exchange risk is the risk that the Company will be subject to foreign currency fluctuations in satisfying obligations related to foreign activities. Loans payable to unrelated third parties may be denominated in Canadian dollars. Foreign exchange risk arises from purchase transactions as well as financial assets and liabilities denominated in these foreign currencies. The Company does not use derivative instruments to hedge exposure to foreign exchange rate risk. However, management of the Company believes there is no significant exposure to foreign currency fluctuations.


5. EQUIPMENT


On June 22, 2017, the Company purchased computer equipment totaling $364,590. The equipment was pledged as security on a loan (See Note 7(b)). Pursuant to the terms of the loan, should the loan remain unpaid past September 30, 2017, the lender would take sole possession of the equipment. The Company did not make the required payment and the equipment was returned to the lender. As at April 30, 2019 and 2018, the Company had no equipment.


6. PREPAID EXPENSES AND OTHER ASSETS


The Company’s prepaid expenses and other assets consists of deposits, retainers and advance payments for various services including investor relations, legal, marketing and other costs.


7. RELATED PARTY TRANSACTIONS AND BALANCES


(a)

During the year ended April 30, 2019, the Company made payments totaling $339,554 related to expenses overseen by the former CFO, President and Chairman of the Board. The Company has not been provided invoices or other support for these expenses. The Company intends to recover the full amount of $339,554, from the former CFO, President and Chairman of the Board, however ultimate collection is uncertain as at April 30, 2019 and the full amount has been written off as allowance for receivables.

 

As at April 30, 2019, the Company has a balance due from related parties, net of allowances for uncollectible receivables, of $Nil (2018 - $327,541). The amount is unsecured, non-interest bearing and due on demand.

 

 

(b)

On June 22, 2017, the Company entered into a secured loan with a corporation with a significant shareholder for a loan up to CAD$450,000 for the purpose of purchasing digital currency mining hardware (“Mining Hardware”). The loan was non-interest bearing and due on August 31, 2017. The Mining Hardware purchased with the loaned funds was held as collateral until the loan amount was fully repaid. Furthermore, revenue produced by the Mining Hardware purchased with the loaned funds was to be paid to the Lender until the loaned funds were repaid in full. Should the loan remain unpaid past September 30, 2017, the Lender would take sole possession of the Mining Hardware, in lieu of the loan. The Company did not make the required payment of the loan by September 30, 2017, and as a result, the Lender took sole possession of the Mining Hardware (refer to Note 5).

 

 

(c)

Certain directors and a relative of a director received a total of $1,875,000 in stock-based compensation upon a transfer of shares on October 30, 2018 as described in Note 14.


F-9



8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES


Accounts payable and accrued liabilities consist of the following:


 

 

April 30,
2019

 

April 30,
2018

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

345,181

 

$

259,420

 

Accrued liabilities

 

 

3,014

 

 

34,863

 

Interest payable

 

 

225,420

 

 

10,454

 

 

 

$

573,615

 

$

304,737

 


9. LOANS PAYABLE


The balance presented for loans payable consist of the following amounts:


(a)

On July 15, 2016, the Company entered into a loan agreement for a principal balance of up to $50,000 at any given time. The amount is unsecured, non-interest bearing and was due on July 15, 2018. As at April 30, 2018, the Company has received gross loan proceeds of $54,176. Upon receipt of the funds, the Company recorded fair value discounts of $6,836. During the year ended April 30, 2017, the Company repaid $10,600 of principal and recognized accretion of the discount of $2,067. During the year ended April 30, 2018, the Company repaid $5,000 of principal and recognized accretion of the discount of $3,918. During the year ended April 30, 2019, the Company repaid $nil of principal and recognized accretion of the discount of $851. At April 30, 2019, the net carrying value of the loan was $38,576 which is due on demand.

 

 

(b)

As at April 30, 2019, the Company was indebted for loans amounting to $500 (2018 - $500). The amounts are unsecured, non-interest bearing and due on demand.

 

 

(c)

On September 15, 2017, the Company entered into a loan agreement for a principal balance of $500,000.  The loan bore interest at 5% per annum and was due on April 30, 2018.  On April 30, 2018, the Company issued 10,630,000 shares of common stock with a fair value of $1,275,600 to settle the $500,000 of principal and $31,250 owed under the loan agreement.  The Company recorded a loss on settlement of debt of $744,350 during the year ended April 30, 2018.

 

 

(d)

On September 30, 2017, the Company entered into a loan agreement for a principal balance of $130,000.  The loan was subject to interest at 10% per annum and due on April 30, 2018. On May 24, 2018, the Company issued 2,600,000 shares of common stock to settle the $130,000 of principal and $6,500 of interest owing under the loan agreement (refer to Note 14). The fair value of the shares issued was determined to be $338,000, and as a result, the Company recorded a loss on settlement of debt of $201,500 during the year ended April 30, 2019.

 

 

(e)

On February 14, 2018, the Company entered into a loan agreement for a principal balance of $25,000.  The loan bears interest at 10% per annum and was due on February 13, 2019. The loan remains unpaid at April 30, 2019.

 

 

(f)

On April 23, 2018, the Company entered into a loan agreement for a principal balance of $15,000.  The loan bears interest at 10% per annum and was due on May 15, 2018. The loan was repaid during the year ended April 30, 2019.


10. CONVERTIBLE DEBENTURES


(a)

On November 27, 2017, the Company entered into and closed on a Securities Purchase Agreement (“SPA”) with Bellridge Capital L.P. (“Bellridge”), pursuant to which the Company issued a senior secured convertible promissory note in the aggregate principal amount of $526,316 (“Note”) for an aggregate purchase price of $500,000, net of a $26,316 original issue discount (“OID”) and $10,000 of legal fees. The Company also incurred additional debt issuance costs of $50,000. The total debt issue costs of $86,316 have been netted against the principal and will be amortized over the term of the loan using the effective interest rate method. In addition, the Company issued 7,894,737 warrants to Bellridge exercisable after a period of six months at an exercise price equal to the lesser of (i) $0.10 per share and (ii) 70% of the lowest traded price of the Company’s common stock during the prior twenty consecutive trading days. The Company also agreed to issue 2,793,296 shares to Bellridge in connection with the loan. The interest on the outstanding principal due under the Note accrued at a rate of 5% per annum. All principal and accrued interest under the Note was due on November 27, 2018 and is convertible into shares of the Company’s Common Stock at a conversion price equal to the lesser of (i) $0.10 and (ii) 70% of the lowest traded market price in the 20 consecutive trading days prior to the conversion date.


F-10



 

The Company evaluated whether separate financial instruments with the same terms as the conversion features above would meet the characteristics of a derivative instrument as described in paragraphs ASC 815-15-25. The terms of the contracts did not permit net settlement, as the shares to be delivered upon conversion are not readily convertible to cash. The Company’s trading history indicated that the shares are thinly traded and the market would not absorb the sale of the shares issued upon conversion without significantly affecting the price. As the conversion features would not meet the characteristics of a derivative instrument as described in paragraphs ASC 815-15-25, the conversion features were not required to be separated from the host instrument and accounted for separately. As a result, at April 30, 2019, the conversion features and non-standard anti-dilutions provisions would not meet derivative classification.

 

The relative fair values of the convertible note, the warrants and the shares were $140,733, $284,751 and $100,832, respectively. The effective conversion price was then determined to be $0.063. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the shares issuable of $100,832 and an equivalent discount that reduced the carrying value of the convertible debt to $425,484. The Company then recognized the relative fair value of the warrants of $284,751 as additional-paid-in capital and an equivalent discount that further reduced the carrying value of the convertible debt to $140,733. The beneficial conversion feature of $54,417, the OID of $26,316 and debt financing costs of $60,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $0. The discount was being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability associated with the debenture under ASC 815-15 Derivatives and Hedging.

 

On November 27, 2018, the Company defaulted on the convertible note, resulting in the note becoming immediately due and payable. Upon default, the interest rate increased to 29% per annum and the Company incurs a late fee at an interest rate equal to 18% per annum on any overdue and unpaid interest under the convertible note. Additionally, the total amount owed on the convertible note upon default is equal to 130% of the outstanding principal and accrued and unpaid interest. During the year ended April 30, 2019, the Company recorded accretion of discount of $490,305 (2018 - $36,010) and a 30% principal increase of $157,895 (2018 - $nil) as a result of default, increasing the carrying value of the loan to $684,211. As at April 30, 2019, the Company has recorded accrued interest of $125,796 (2018 - $10,454).


b)

On April 2, 2018, April 5, 2018 and April 13, 2018, the Company amended (the “Amendments”) the November 27, 2017 Securities Purchase Agreement. Pursuant to the Amendments the Company issued Bellridge warrants to purchase 85,000,000 shares of the Company’s common stock at an exercise price of $0.10 per share. The Company also issued a senior secured convertible promissory note in the aggregate principal amount of $315,790 (“Note”) for an aggregate purchase price of $295,000, net of a $15,790 OID and $5,000 of legal fees. The Company also incurred additional debt issuance costs of $30,000 and issued a warrant to purchase 560,717 shares of the Company’s common stock at an exercise price of $0.10 per share. The total debt issue costs of $50,672 have been netted against the principal and will be amortized over the term of the loan using the effective interest rate method. The interest on the outstanding principal due under the Note accrued at a rate of 5% per annum. All principal and accrued interest under the Note was due on December 20, 2018 and was convertible into shares of the Company’s Common Stock at a conversion price equal to the lesser of (i) $0.10 and (ii) 70% of the lowest traded market price in the 20 consecutive trading days prior to the conversion date.

 

The relative fair values of the convertible note, the warrants and the shares were $6,208, $118 and $258,674, respectively. The effective conversion price was then determined to be $0.001. As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company recognized the relative fair value of the warrants of $258,792, as additional-paid-in capital and an equivalent discount that reduced the carrying value of the convertible debt to $56,998. The beneficial conversion feature of $6,208, the OID of $15,790 and debt financing costs of $35,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $0. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability associated with the debenture under ASC 815-15 Derivatives and Hedging.

 

On December 20, 2018, the Company defaulted on the convertible note, resulting in the note becoming immediately due and payable. Upon default, the interest rate increased to 29% per annum and the Company incurs a late fee at an interest rate equal to 18% per annum on any overdue and unpaid interest under the convertible note. Additionally, the total amount owed on the convertible note upon default is equal to 130% of the outstanding principal and accrued and unpaid interest. During the year ended April 30, 2019, the Company recorded accretion of discount of $307,009 (2018 - $8,781) and a 30% principal increase of $94,737 (2018 - $nil) as a result of default, increasing the carrying value of the loan to $410,527. As at April 30, 2019, the Company has recorded accrued interest of $61,101 (2018 - $1,524).


F-11



c)

On June 1, 2018, the Company issued a senior secured convertible promissory note in the aggregate principal amount of $210,527 (“Note”) for an aggregate purchase price of $200,000, net of a $10,527 OID. The Company also incurred additional debt issuance costs of $20,000. The total debt issue costs of $30,527 have been netted against the principal and will be amortized over the term of the loan using the effective interest rate method. The interest on the outstanding principal due under the Note accrues at a rate of 5% per annum. All principal and accrued interest under the Note is due on June 1, 2019 and is convertible into shares of the Company’s Common Stock at a conversion price equal to the lesser of (i) $0.10 and (ii) 70% of the lowest traded market price in the 20 consecutive trading days prior to the conversion date.

 

As the stock price at the issuance date was greater than the effective conversion price, it was determined that there was a beneficial conversion feature. The Company then recognized the beneficial conversion feature of $144,908 as additional-paid-in capital and an equivalent discount that further reduced the carrying value of the convertible debt to $65,619. The OID of $10,570 and debt financing costs of $20,000 discounted the convertible debenture such that the carrying value of the convertible debt on the date of issue was $35,092. The discount is being expensed over the term of the loan to increase the carrying value to the face value of the loan. The Company determined that there was no derivative liability associated with the debenture under ASC 815-15 Derivatives and Hedging.

 

On December 20, 2018, the Company defaulted on the convertible note, resulting in the note becoming immediately due and payable. Upon default, the interest rate increased to 29% per annum and the Company incurs a late fee at an interest rate equal to 18% per annum on any overdue and unpaid interest under the convertible note. Additionally, the total amount owed on the convertible note upon default is equal to 130% of the outstanding principal and accrued and unpaid interest. During the year ended April 30, 2019, the Company recorded accretion of discount of $175,435 (2018 - $nil) and a 30% principal increase of $63,158 (2018 - $nil) as a result of default, increasing the carrying value of the loan to $273,685. As at April 30, 2019, the Company has recorded accrued interest of $38,542 (2018 - $nil).

 

As part of the SPA, Bellridge is loaning the Company a minimum of $500,000 to a maximum of $1,500,000 (“Loan”). The first three tranches were the $1,000,000 in the form of the Notes above. The next and final tranche of $500,000 will be funded upon the effectiveness of the registration statement that the Company is required to file covering the shares of common stock issuable upon conversion of the Notes.

 

As part of the Bellridge Agreements, the Company also executed Registration Rights Agreement, Intellectual Property Security Interest Agreement, Subsidiary Guaranty and a Security Interest Agreement in all the Company’s assets to Bellridge.


11. LICENSE


On November 6, 2017 the Company issued 60,000,000 shares of common stock pursuant to the terms of an Exclusive Software License Agreement (the “Agreement”) with Black Cactus Holdings, LLC (“Black Cactus LLC”) to acquire an exclusive software license for the Black Cactus blockchain development software platform and related intellectual property (the “Software”) and the Agreement includes a service contract with the CEO of Black Cactus LLC to join the Company as a director and officer. The Company did not receive the use of the Software platform and accordingly no asset has been recognized. Consulting costs of $228,000 incurred in connection with the Agreement were recorded in expenses during the year ended April 30, 2018. On April 25, 2018, the Company and Black Cactus LLC agreed to terminate the Agreement and the 60,000,000 shares of common stock issued pursuant to the agreement were returned to the Company for cancellation.


12. PRODUCT DEVELOPMENT AND WEBSITE COSTS


On June 18, 2017, the Company entered into a Definitive Acquisition Agreement involving the internet domain and brand BitReturn. The Agreement represented the Company’s development of a plan to create a technology business in mining digital currency with an operating name of BitReturn. The Company issued 10,000,000 shares of restricted common stock with a fair value of $1,900,000 as payment under the terms of the Agreement, which was recognized as and included in product development and website costs. The Company is also to make cash payments totaling $350,000 under the terms of the Agreement, and as at April 30, 2019, $350,000 (2018 - $350,000) is recorded as an amount payable for BitReturn. Product development and website expenses represent costs of acquiring the brand BitReturn, development of the crypto currency mining product, and creation of the website. These costs did not meet the criteria for capitalization, and therefore were treated as an operating expense in fiscal 2018. During the year ended April 30, 2019, the Company determined it would not proceed with its plan to create a technology business in mining digital currency.

.


F-12



13. COMMITMENTS


(a)

On July 1, 2017, the Company entered into a Strategic Management and Advisory Agreement for consulting services and investor relations services to be provided over a period of twelve months commencing July 1, 2017. In consideration, the Company paid a total monthly fee of $3,000 cash and issued a total of 1,000,000 shares of common stock. On July 26, 2017, the Company issued 1,000,000 shares of common stock with a fair value of $260,000, which was recorded as a prepaid expense and amortized over the term of the agreement. During the year ended April 30, 2019, the Company recognized $43,333 (2018 - $216,666) of consulting expense.

 

 

(b)

On November 8, 2017, the Company entered into a Financial Advisor Agreement with an unrelated third party for consulting services and investor relations services to be provided over a period of three months commencing November 8, 2017. In consideration, the Company paid an initial fee of $20,000 cash. In addition, if the Company closed any transactions made with any introduction made by the unrelated third party, the Company would pay an industry-standard cash fee of 10% on all equity or equity-linked capital invested, which will be recorded as debt financing costs. On November 27, 2017, the Company entered into and closed on a Securities Purchase Agreement (refer to Note 10) whereby the introduction was made by the unrelated third party. During the year ended April 30, 2018, the Company recognized $100,000 of debt financing costs (refer to Note 10) and issued 560,717 warrants exercisable at $0.10 pursuant to the agreement. During the year ended April 30, 2019, the Company recognized $20,000 of debt financing costs (refer to Note 10).

 

 

(c)

On December 19, 2017, the Company entered into a Business Development Consultant Agreement for consulting services to be provided over a period of twelve months commencing December 19, 2017. In consideration, the Company paid a monthly fee of GBP10,000 cash and issued a total of 2,000,000 shares of common stock.. During the year ended April 30, 2018, the Company recognized $660,000 of consulting expense for the fair value of 2,000,000 common shares that was issued in February 2018. On April 26, 2018, the Company and the consultant entered into a Termination Agreement pursuant to which the agreement was terminated. Pursuant to the Termination Agreement, no further consideration is due and the consultant retained the 2,000,000 shares of common stock.

 

 

(d)

On January 4, 2018, the Company entered into an Equity Research Service Agreement for investor relations services to be provided over a period of twelve months commencing January 4, 2018. In consideration, on January 16, 2018, the Company issued 150,000 shares of common stock with a fair value of $57,000, which was recorded as a prepaid expense and amortized over the term of the agreement. During the year ended April 30, 2019, the Company recognized $28,500 (2018 - $19,000) of consulting expense.

 

 

(e)

On February 14, 2018, the Company entered into an Employment Agreement with a term of three years. Pursuant to the Employment Agreement, the Company agreed to issue 8,000,000 shares and pay the employee GBP250,000 in exchange for services. On July 9, 2018, the Company and the employee entered into a Settlement and General Release Agreement pursuant to which, the Company was to be issue the employee 6,000,000 shares of common stock in exchange for release from the Employment Agreement and the fair value of $420,000 of the shares issuable (refer to Note 14) was expensed in July 2018.


14. STOCK


On November 13, 2017, the Company amended its Articles of Incorporation, increasing the number of common stock authorized from 240,000,000 to 490,000,000, par value of $0.0001, and leaving the number of preferred stock authorized at 10,000,000, par value of $0.0001.


At the time of the amendment, the Company designated 10,000 shares of its authorized but unissued shares of preferred stock as Series A Preferred Stock. The 10,000 Series A Preferred Stock shall have an aggregate voting power of 45% of the combined voting power of the entire Company’s shares, common stock and preferred stock, as long as the Company is in existence. Each holder of the Series A Preferred Stock shall have full voting rights and powers equal to the voting rights and powers of the holders of common stock, and shall be entitled, notwithstanding any provision hereof, to notice of any stockholders’ meeting in accordance with the by-laws of the Company, and shall be entitled to vote, together with holders of common stock, with respect to any question upon which holders of common stock have the right to vote. Without the vote or consent of holders of at least a majority of the shares of Series A Preferred Stock then outstanding, the Company may not (i) authorize, create or issue, or increase the authorized number of shares of, any class or series of capital stock ranking prior to or on a parity with the Series A Preferred Stock, (ii) authorize, create or issue any class or series of common stock of the Company other than the common stock, (iii) authorize any reclassification of the Series A Preferred Stock, (iv) authorize, create or issue any securities convertible into or exercisable for capital stock prohibited by (i) or (ii), (v) amend this Certificate of Designations or (vi) enter into any merger or reorganization, or disposal of assets involving 20% of the total capitalization of the Company.


F-13



Subject to the rights of the holders of any other series of preferred stock ranking senior to or on a parity with the Series A Preferred Stock with respect to liquidation and any other class or series of capital stock of the Company ranking senior to or on a parity with the Series A Preferred Stock with respect to liquidation, in the event of any liquidation, dissolution or winding up of the affairs of the Company, whether voluntary or involuntary, the holders of record of the issued and outstanding shares of Series A Preferred Stock shall be entitled to receive, out of the assets of the Company available for distribution to the holders of shares of Series A Preferred Stock, prior and in preference to any distribution of any of the assets of the Company to the holders of common stock and any other series of preferred stock ranking junior to the Series A Preferred Stock with respect to liquidation.


The holders of the Series A Preferred Stock shall not be entitled to receive dividends per share of Series A Preferred Stock. The Company shall have no rights to redeem Series A Preferred Stock.


COMMON STOCK


On June 26, 2017, the Company issued 1,400,000 shares of common stock for gross proceeds of $14,000, which was received during the year ended April 30, 2017.


On June 27, 2017, the Company issued 10,000,000 shares of common stock with a fair value of $1,900,000 for BitReturn pursuant to a Definitive Acquisition Agreement (refer to Note 12).


On July 1, 2017, the Company issued 1,000,000 shares of common stock with a fair value of $260,000 for investor relations services pursuant to a Strategic Management and Advisory Agreement (refer to Note 13(a)).


On July 26, 2017, the Company issued 2,500,000 shares of common stock with a fair value of $400,000 as signing bonuses pursuant to service agreements and the $400,000 fair value was expensed and included in consulting fees.


On November 6, 2017, the Company issued 60,000,000 shares of common stock with a fair value of $6,600,000 for a license fee pursuant to the Exclusive Software License Agreement. On April 27, 2018, the agreement was terminated and the 60,000,000 shares were cancelled (refer to Note 11).


On January 16, 2018, the Company authorized 3,200,000 shares of common stock to be issued pursuant to the Share Purchase Agreement with an unrelated third party and these shares remained held in treasury. Under the terms of the Agreement, the Company will purchase all the issued ordinary shares of the unrelated third party from its shareholders, thereby acquiring all the intellectual property, research and development, contracts, accounts receivable and licenses owned by the unrelated third party. In exchange, the Company will issue 3,200,000 shares of its common stock to the unrelated third party’s shareholders. The Agreement will not close and the acquisition will not be complete until the Company receives the source code and software to the unrelated third party’s intellectual property for all of the unrelated third party’s programs, platforms and products and these assets have been independently verified. Additionally, if the shares issued to the unrelated third party shareholders do not have an aggregate value of $2,000,000 by January 15, 2019, the unrelated third party shareholders are entitled to have additional shares issued to them so that they hold shares equal to $2,000,000 as of that date. As the Company has not received the source code and software relating to the intellectual property, the Agreement was terminated, and the 3,200,000 common shares held in treasury were cancelled on May 23, 2018.


On January 16, 2018, the Company issued 150,000 shares of common stock with a fair value of $57,000 for investor relations services pursuant to an Equity Research Services Agreement (refer to Note 13(d)).


On February 5, 2018, the Company issued 2,000,000 shares of common stock with a fair value of $660,000 for consulting services pursuant to a Business Development Agreement (refer to Note 13(c)).


On April 20, 2018, the Company issued 2,793,296 shares of common stock with a fair value of $100,832 as financing fees pursuant to the Securities Purchase Agreement (refer to Note 10).


On April 30, 2018, the Company issued 10,630,000 shares of common stock to settle the $500,000 of principal and $31,250 owed under a loan agreement (refer to Note 9(c)).


On May 24, 2018, the Company issued 2,600,000 shares of common stock to settle the $130,000 of principal and $6,500 owed under a loan agreement (refer to Note 9(d)).


F-14



On July 9, 2018, the Company entered into a Settlement and General Release Agreement pursuant to which the Company would issue an employee 6,000,000 shares of common stock in exchange for release from an Employment Agreement (refer to Note 13(e)). The fair value of the shares on the date of settlement of $420,000 is presented as of April 30, 2019 as shares issuable because the shares have not been issued to date.


On April 27, 2018, the Company issued an aggregate of 50,000,000 shares of common stock in certificated form to three directors and a relative of one of the directors. These four certificates were maintained in the possession of the Company and/or its transfer agent until October 30, 2018, on which date all 50,000,000 shares were transferred into book entry form registered in the name of the four individuals.  The Company’s financial statements prior to October 30, 2018, reflected the 50,000,000 shares as treasury shares.  Upon the transfer of such shares of common stock into book entry form, on October 30, 2018, the shares became issued and outstanding shares of the Company and are no longer reflected as treasury shares in the Company’s financial statements. Based upon the quoted market price, the total value of the shares was $1,875,000 on the date of the transfer which was recorded as a stock-based compensation expense on October 30, 2018 as no assets were received by the Company in exchange for the shares.


As at April 30, 2019, there are 166,073,296 shares of common stock issued and outstanding.


PREFERRED STOCK - SERIES A


As at April 30, 2019, there are no issued and outstanding Series A Preferred Stock.


15. SHARE PURCHASE WARRANTS


The following table summarizes the continuity of share purchase warrants:


 

 

Number of
warrants

 

Weighted average
exercise price
$

 

 

 

 

 

 

 

Balance, April 30, 2017

 

 

 

 

Issued

 

93,455,454

 

 

0.10

 

Balance, April 30, 2018

 

93,455,454

 

 

0.10

 

Issued

 

 

 

 

Balance, April 30, 2019

 

93,455,454

 

 

0.10

 


As at April 30, 2019, the following share purchase warrants were outstanding:


Number of
warrants

 

Exercise price
$

 

Expiry date

 

 

 

 

 

 

 

7,894,737

 

0.0042*

 

May 27, 2022

 

560,717

 

0.10

 

March 29, 2023

 

85,000,000

 

0.10

 

April 5, 2023

 

93,455,454

 

 

 

 

 

__________

*The lower of $0.10 and 70% of the lowest traded price of the Company’s common stock during the prior twenty consecutive trading days.


The weighted average remaining life of the warrants outstanding as at April 30, 2019 is 3.86 years.


F-15



16. INCOME TAXES


The Company is subject to United States federal and state income taxes at an approximate rate of 21%. The reconciliation of the provision for income taxes at the United States federal and state statutory rate compared to the Company’s income tax expense as reported is as follows:


 

 

April 30,
2019
$

 

April 30,
2018
$

 

 

 

 

 

 

 

 

 

Net loss

 

$

4,294,852

 

$

5,988,299

 

Income tax rate

 

 

21%

 

 

21%

 

Expected income tax benefit

 

 

(909,919

)

 

(1,257,543

)

Accretion

 

 

204,278

 

 

9,406

 

Loss on settlement of debt

 

 

42,315

 

 

156,314

 

Write-off loan advanced

 

 

 

 

10,500

 

Valuation allowance change

 

 

655,326

 

 

1,081,323

 

Provision for income taxes

 

$

 

$

 


The significant components of deferred income tax assets at April 30, 2019 and 2018, are as follows:


 

 

April 30,
2019
$

 

April 30,
2018
$

 

 

 

 

 

 

 

 

 

Net operating loss carryforward

 

$

1,779,191

 

$

1,123,864

 

Valuation allowance

 

 

(1,779,191

)

 

(1,123,864

)

Net deferred income tax asset

 

$

 

$

 


The Company has net operating loss carryforwards of approximately $8,472,337 available to offset taxable income in future years which expires beginning in fiscal 2033. The Company has recognized a valuation allowance for the deferred income tax asset since the Company cannot be assured that it is more likely than not that such benefit will be utilized in future years.


17. SUBSEQUENT EVENTS


On August 24, 2019, the Company entered into a Software License Agreement (“License Agreement”) with Charteris, Mackie, Baillie & Cummins Limited (“CMBC Limited”) to acquire a non-exclusive license for Black Cactus blockchain development software platform and related intellectual property (“Software”) which are licensed to CMBC Limited from Black Cactus LLC. As consideration, the Company shall pay CMBC Limited a royalty in the amount of five percent (5%) of the gross revenue received from the sublicense of the Software (“royalty”), due on a quarterly basis, and issue or assign an equivalent number of common shares to CMBC Limited that will represent 60% of the then issued shares of the Company. In addition, the Company will issue an option for CMBC Limited to acquire additional shares at par value ($0.0001) per share up to 60% of any shares issued under the existing Securities Purchase Agreements with Bellridge (Note 10). The closing of the License Agreement is conditional on the Company obtaining a written agreement with Bellridge to increase its line of credit from $1,500,000 to $5,000,000 (Note 10), and the assignment of a separate Software License Agreement between CMBC Limited and Benchmark Advisors Limited (“Benchmark”) originally granted to Benchmark on February 20, 2019.


During November 2019, the Company entered into an Assignment Agreement with CMBC Limited to acquire the assignment of a non-exclusive software license (“License”) for Software from Benchmark. As consideration for the assignment of the License, CMBC will be paid $250,000 directly from Bellridge on behalf of the Company as part of the increased line of credit of $5,000,000.


F-16